IP Library Granted Patent US 9,265,941
Granted Patent B2
US 9,265,941 · App. 14/682,564 · Granted Feb 23, 2016

Lead set for nerve stimulator and method of operation thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,265,941
App. No.
14/682,564
Granted
Feb 23, 2016
Kind
B2
Abstract

Single-use electrical leads for a nerve stimulator are disclosed. The nerve stimulator has a “test mode” that determines a current value for treatment, and a “therapy mode” that administers treatment with the chosen current value. Preferably the fuse is electrically isolated from the leads that contact the patient.

Claims (10)

1. A lead set for electro-nerve stimulation, comprising:

a connector having a first port and a second port;

an electrically conductive transcutaneous electrode;

a first electrically conductive insulated lead wire having a first end fixedly secured to the connector and a second end fixedly secured to the electrically conductive transcutaneous electrode, the first port corresponding to the first electrically conductive insulated lead wire;

an electrically conductive adaptor adapted to electrically couple with an electrically conductive percutaneous needle electrode; and

a second electrically conductive insulated lead wire having a first end fixedly secured to the connector and a second end fixedly secured to the electrically conductive adaptor, the second port corresponding to the second electrically conductive insulated lead wire;

the connector being a single-use connector adapted to discourage or make difficult re-use of the lead set for electro-nerve stimulation, said connector including a fuse having a functional status that is changeable during delivery of therapy after a pre-determined period of time from an operational condition to a non-operational condition wherein the non-operational condition does not prevent continued delivery of said therapy.

2. The lead set of claim 1 wherein:

the connector comprises a third port, a fourth port, and said fuse is configured to be coupled between the third port and the fourth port; and

the electrically conductive adaptor comprises an electrically conductive clip.

Assignments (4)
SECURITY INTEREST Recorded Apr 2, 2024
From: CLINICAL INNOVATIONS, LLC; COGENTIX MEDICAL, INC.; UROPLASTY, LLC; GI SUPPLY, INC.; LABORIE MEDICAL TECHNOLOGIES CANADA ULC; LABORIE MEDICAL TECHNOLOGIES CORP.; MEDICAL MEASUREMENT SYSTEMS B.V.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066986/0500 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Feb 12, 2020
From: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
To: COGENTIX MEDICAL, INC.; LABORIE MEDICAL TECHNOLOGIES CANADA ULC; UROPLASTY LLC
Reel/Frame 051906/0518 →
SECURITY INTEREST Recorded Apr 23, 2018
From: COGENTIX MEDICAL, INC.; UROPLASTY LLC; LABORIE MEDICAL TECHNOLOGIES CANADA ULC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 045609/0561 →
MERGER AND CHANGE OF NAME Recorded Apr 16, 2015
From: UROPLASTY, INC.; VISOR MERGER SUB LLC
To: UROPLASTY, LLC
Reel/Frame 035426/0303 →